Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Peer Review channel feed
Bayer’s radiology head plans retirement; Ex-Sanofi chief Olivier Brandicourt joins BeiGene’s board
Last year
People
Neuroscience legend Steve Paul retires; Exclusive: GSK hires ex-Innate Pharma CEO for new position
Last year
People
Ex-Celgene chief Mark Alles, former Goldfinch Bio leader Tony Johnson are back in the game as CEOs
Last year
People
Evotec CEO Werner Lanthaler resigns; After Novo deal, ex-Forma chief ushers in new era at Pacira
Last year
People
Deck the halls with resignations: LianBio CEO, CFO out; CRISPR Therapeutics CMO to leave in January
Last year
Interim no more: Ashley Magargee to fill Genentech CEO post; Pfizer, Moderna make commercial leadership adjustments
Last year
Ex-Cedilla CEO Glucksmann explores ‘new frontier’ at Sensorium; R&D chief out at Merck women’s health spinoff Organon
Last year
Amylyx hires new CMO from Ultragenyx; Eliot Forster is back as a CEO after F-star sale
Last year
Design Therapeutics hints at ‘strategic realignment,’ replaces CEO; Karyopharm co-founder leads ATP's Nereid
Last year
Century Therapeutics nabs Bristol Myers alum as CEO; Enhertu star Daiichi Sankyo makes changes in Europe
Last year
CNS biotech Rapport snags a CFO veteran from Karuna; Bristol Myers’ new CEO to chair the board next year
Last year
Flagship's Montai Health hires first CMO; Finance leader to retire at J&J partner Xencor
Last year
Co-founded by David Baker, Vilya rings in a permanent CEO; Allogene names Eric Schmidt's CFO successor
Last year
Poseida promotes cell therapy president to CEO; After IPO, Neumora appoints R&D chief
Last year
Dave Lennon's CEO adventure goes from preclinical to commercial; GSK vet embarks on new Odyssey with Gary Glick
Last year
People
Exclusive: Former Genentech duo reunites to push Sonoma into the clinic; Ex-Magenta commercial chief heads to Editas
Last year
Mark Velleca takes over at Black Diamond; Verve Therapeutics separates CMO, CSO posts
Last year
Phil Vickers talks new role as head of Longwood’s Solu after Faze shutdown; Regeneron CFO to retire in February
Last year
Glyscend taps CEO to lead oral obesity, type 2 diabetes candidate; Ex-Travecta chief bounces back after company shutdown
Last year
David Khougazian joins Flagship to build ‘partnerships with different flavors’; Former Novo Nordisk exec to lead Evaxion
Last year
Bayer enlists Jürgen Eckhardt to leap into an additional role; Mirati tops list of multiple CFO exits
Last year
Flagship recruits ex-Magenta CEO to lead Ampersand; Biogen's head of research leaves for Alltrna
Last year
Voyager taps new business chief amid 'significant interest' from partners; Oncopeptides faces another CEO, CFO reset
Last year
Brent Saunders keeps rolling out the changes at Bausch + Lomb; Incyte CSO to exit next month
Last year
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page
